Abstract
Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl2. HA-1 was found to block microtubule polymerisation in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes - themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications.
Supplementary materials
Title
Supplementary Information
Description
Further experimental details
Actions
Title
Movie S1
Description
Computational simulation of DAMA-colchicine in the stathmin-like domain complex (PDB code: 1SAO), overlayed with HA-1, followed by CA4.
Actions
Title
Movie S2
Description
Computational simulation of DAMA-colchicine in the stathmin-like domain complex (PDB code: 1SAO), overlayed with HA-1, followed by CA4.
Actions
Title
Movie S3
Description
Computational simulation of colchicine in the tubulin-colchicine complex (PDB code: 4O2B), overlayed with HA-1, followed by CA4.
Actions
Title
Movie S4
Description
Computational simulation of colchicine in the tubulin-colchicine complex (PDB code: 4O2B), overlayed with HA-1, followed by CA4.
Actions
Title
Movie S5
Description
Inhibition of microtubule dynamics by HA-1 (data related to Figure 3). No-cosolvent, and 1% DMSO, control phases (baseline dynamics) precede HA-2 phase (as indicated by captioning; 20 µM HA-1; EB3-GFP transiently transfected HeLa cells).
Actions
Title
Movie S6
Description
No inhibition of microtubule dynamics by HA-2 (data related to Figure 3). No-cosolvent, and 1% DMSO, control phases (baseline dynamics) precede HA-2 phase (as indicated by captioning; 20 µM HA-2; EB3-GFP transiently transfected HeLa cells).
Actions
Title
X-ray data
Description
X-ray data for crystallised small molecules
Actions